Cytokine gene polymorphisms in retinal detachment patients with and without proliferative vitreoretinopathy: A preliminary study

Acta Ophthalmologica Scandinavica

Volumn 84, Issue 3, 2006, Pages 309-313

  Sanabria Ruiz Colmenares, Maria Rosa ^a   Pastor Jimeno, José Carlos ^a   Garrote Adrados, José Antonio ^b   Telleria Orriols, Juan José ^b   Yugueros Fernández, Maria Isabel ^b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Cytokine gene polymorphism; Proliferative vitreoretinopathy; Retinal detachment; Risk factors

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PATIENT CODING; PRIORITY JOURNAL; RETINA DETACHMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; VITREORETINOPATHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CYTOKINES; DNA; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RETINAL DETACHMENT; RISK FACTORS; VITREORETINOPATHY, PROLIFERATIVE;

EID: 33646774298     PISSN: 13953907     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1600-0420.2005.00600.x     Document Type: Article

References (22)

1. Asaria RH, Kon CH, Bunce C, Charteris DG, Wong D, Luthert PJ, Khaw PT & Aylward GW (2001): How to predict proliferative vitreoretinopathy. A prospective study. Ophthalmology 108: 1184-1186.
2. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ & Hutchinson IV (1998): Genotypic variation in the transforming growth factor-β1 gene: Association with transforming growth factor-β1 production, fibrotic lung disease and graft fibrosis after lung transplantation. Transplantation 66: 1014-1020.
3. Clancy RM, Backer CB, Yin X, Kapur RP, Molad Y & Buyon JP (2003): Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-α and TGF-β1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 171: 3253-3261.
4. Connor TB, Roberts AB, Sporn MB et al. (1989): Correlation of fibrosis and transforming growth factor-β2 levels in the eye. J Clin Invest 83: 1661-1666.
5. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S & Woo P (1998): The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376.
6. Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S & Gressner AM (2002): Association of polymorphisms of the transforming growth factor-β1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 316: 83-94.
7. Hauck EW, Hauptmann A, Schmelz HU, Bein G, Weidner W & Hackstein H (2003): Prospective analysis of single nucleotide polymorphisms of the transforming growth factor-β1 gene in Peyronie's disease. J Urol 169: 369-372.
8. Haukim N, Bidwell JL, Smith AJP et al. (2002): Cytokine gene polymorphism in human disease: On line databases. Genes Immun 3 (0): 313-330.
9. Kon CH, Occleston NL, Aylward GW & Khaw PT (1999): Expression of vitreous cytokines in proliferative vitreoretinopathy: A prospective study. Invest Ophthalmol Vis Sci 40: 705-712.
10. Libura J, Bettens F, Radkowski A, Tiercy JM & Piguet PF (2002): Risk of chemotherapy-induced pulmonary fibrosis is associated with polymorphic tumour necrosis factor-α2 gene. Eur Respir J 19: 912-918.
11. Pastor JC (1998): ProliferaAive vitreoretinopathy: an overview. Surv Ophthalmol 43: 3-18.
12. Pastor JC, Rodríguez de la Rua E & Martín F (2002): Proliferative vitreoretinopathy: Risk factors and pathobiology. Prog Retin Eye Res 21: 127-144.
13. Perrey C, Pravica V, Sinnott PJ & Hutchinson IV (1998): Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-α genes: A technical report. Transpl Immunol 6: 193-197.
14. Powell EE, Edwards-Smith CJ, Hay JL, Clouston AD, Crawford DH, Shorthouse C, Purdie DM & Jonsson JR (2000): Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31: 828-833.
15. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ & Hutchinson IV (1999): In vitro production of IFN-γ correlates with CA repeat polymorphism in the human IFN-ã gene. Eur J Immunogenet 26: 1-3.
16. Retina Society Terminology Committee (1983): The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 90: 121-125.
17. Riha RL, Yang IA, Rabnott GC, Tunnicliffe AM, Fong KM & Zimmerman PV (2004): Cytokine gene polymorphisms in idiopathic pulmonary fibrosis. Intern Med J 34: 126-129.
18. Smith RE, Strieter RM, Phan SH, Lukacs N & Kunkel SL (1998): TNF and IL-6 mediate MIP-1α expression in bleomycin-induced lung injury. J Leukoc Biol 64: 528-536.
19. Tanihara H, Inatani M & Honda Y (1997): Growth factors and their receptors in the retina and pigment epithelium. Prog Retin Eye Res 16: 271-301.
20. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ & Hutchinson IV (1997): An investigation on polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24: 1-8.
21. Wiedemann P (1992): Growth facPors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy and retinal degeneration. Surv Ophthalmol 36: 373-384.
22. Wilson AG, Symons JA, McDowell TL, McDevitt HO & Duff GW (1997): Effects of a polymorphism in the human tumour necrosis factor-α promoter on transcriptional activation. Proc Natl Acad Sci U S A 94: 3195-3199.